Skip to main content
. 2018 Feb 15;15(4):5497–5504. doi: 10.3892/ol.2018.8062

Figure 5.

Figure 5.

Perforin, granzyme B and CD107a expression on target NK cells. (A) The expression of perforin in NK cells in patients with MDS and healthy controls. (B) The relative mRNA expression level of perforin in purified target NK lymphocytes. (C) The expression of granzyme B in NK cells in patients with MDS and controls. (D) The relative mRNA expression level of granzyme B in purified target NK lymphocytes. (E) The expression of CD107a on CD16+NK cells in patients with MDS and healthy controls. (F) CD107a on CD16NK cells in patients with MDS and healthy controls. CD, cluster of differentiation; NK, natural killer; MDS, myelodysplastic syndromes.